Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for United-Guardian, Inc. (UG : NSDQ)
 
 • Company Description   
UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents.

Number of Employees: 24

 
 • Price / Volume Information   
Yesterday's Closing Price: $16.40 Daily Weekly Monthly
20 Day Moving Average: 16,216 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 0.09
52 Week High: $26.09
52 Week Low: $13.68
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -32.57% -24.06%
12 Week -17.05% -8.81%
Year To Date -0.30% 30.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
230 MARCUS BOULEVARD
-
HAUPPAUGE,NY 11788
USA
ph: 631-273-0900
fax: 631-273-0858
None http://www.u-g.com
 
 • General Corporate Information   
Officers
Ken Globus - President;General Counsel and Chairman
Andrea J. Young - Chief Financial Officer;Treasurer and Secretary
Lawrence F. Maietta - Director
Arthur M. Dresner - Director
Andrew A. Boccone - Director

Peer Information
United-Guardian, Inc. (BJCT)
United-Guardian, Inc. (CADMQ)
United-Guardian, Inc. (APNO)
United-Guardian, Inc. (UPDC)
United-Guardian, Inc. (IMTIQ)
United-Guardian, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 910571108
SIC: 2844
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.09
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 7.93%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $1.30
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 1.37
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.27
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 17.26
PEG Ratio: -
Price Ratios
Price/Book: 7.66
Price/Cash Flow: 15.67
Price / Sales: -
EPS Growth
vs. Year Ago Period: -23.08%
vs. Previous Quarter: -16.67%
Sales Growth
vs. Year Ago Period: 13.44%
vs. Previous Quarter: 6.31%
ROE
03/31/22 - 40.90
12/31/21 - 42.62
09/30/21 - 37.54
ROA
03/31/22 - 34.27
12/31/21 - 36.11
09/30/21 - 32.40
Current Ratio
03/31/22 - 6.13
12/31/21 - 4.95
09/30/21 - 7.59
Quick Ratio
03/31/22 - -
12/31/21 - 4.35
09/30/21 - 6.84
Operating Margin
03/31/22 - 30.50
12/31/21 - 33.45
09/30/21 - 32.86
Net Margin
03/31/22 - 30.50
12/31/21 - 33.45
09/30/21 - 32.86
Pre-Tax Margin
03/31/22 - 38.47
12/31/21 - 42.20
09/30/21 - 41.39
Book Value
03/31/22 - -
12/31/21 - 2.14
09/30/21 - 2.55
Inventory Turnover
03/31/22 - 4.77
12/31/21 - 4.65
09/30/21 - 4.38
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©